CellWell record HH-12190
NRF2 pathway activation predicts poor prognosis in lung cancer: a cautionary note on antioxidant interventions.
Ungvari Z; Menyhart O; Lehoczki A; Fekete M; Fazekas-Pongor V; Ocana A; Varga P; Győrffy B
GeroScience · 2026
In plain language
An analysis of over 2,000 lung cancer patients found that higher tumor NRF2 pathway activation, the same antioxidant-defense pathway induced by sulforaphane, was associated with worse survival outcomes.
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-12190
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.